Medartis Holding AGMDRSF 82 PB Ratio is 4.13 as of Jul. 01, 2026, which is 14% above its 10-year median of 3.63. GuruFocus rates MDRSF with a GF Score™ of 82/100 and a GF Value™ of $151.13. The stock has 5 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 71.79% on this metric.
Medartis Holding AG stock PB Ratio (=3.62) is close to 1-year low of 3.34.
The historical rank and industry rank for Medartis Holding AG's PB Ratio or its related term are showing as below:
MDRSF'
s PB Ratio Range Over the Past 10 Years
Min: 1.91 Med: 3.63 Max: 55.41
Current: 3.62
During the past 12 years, Medartis Holding AG's highest PB Ratio was 55.41. The lowest was 1.91. And the median was 3.63.
MDRSF's PB Ratio is ranked worse than 71.79% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.08
vs MDRSF: 3.62
During the past 12 months, Medartis Holding AG's average Book Value Per Share Growth Rate was 2.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 4.30% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Medartis Holding AG was 132.60% per year. The lowest was 0.70% per year. And the median was 4.50% per year.
Back to Basics: PB Ratio
Medartis Holding AG (OTCPK:MDRSF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medartis Holding AG PB Ratio Related Terms
Medartis Holding AG PB Ratio Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medartis Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medartis Holding AG (MDRSF) has a PB Ratio of 4.13 as of Jul. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medartis Holding AG and its competitors. This is 14% above median its historical median of 3.63. Over the past decade, Medartis Holding AG's PB Ratio has ranged from 1.91 to 55.41. According to the industry distribution chart, Medartis Holding AG ranks #565 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 71.8%.
Is Medartis Holding AG's PB Ratio too high?
Medartis Holding AG's current PB Ratio of 4.13 is 14% above median its 10-year median of 3.63. Over the past 10 years, this metric has ranged from a low of 1.91 to a high of 55.41. The Medical Devices & Instruments industry median PB Ratio is 2.08. Medartis Holding AG's value of 4.13 is 98.6% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #565 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #565 out of 787 companies for PB Ratio. This places Medartis Holding AG in the lower half of its industry. The industry median PB Ratio is 2.08. Medartis Holding AG's value of 4.13 is 98.6% above this benchmark. Historically, Medartis Holding AG's own PB Ratio has ranged from 1.91 to 55.41 over the past decade. While the company's 10-year median is 3.63 vs. the industry median of 2.08, Medartis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.08, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current PB Ratio of 4.13 is 98.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current PB Ratio is 4.13, which is 14% above median its own 10-year median of 3.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Medartis Holding AG (MDRSF) has a current PB Ratio of 4.13. The stock's GF Value™ is $151.13, compared to a current price of $115.00 — trading 23.9% below its estimated fair value. The current PB Ratio is 4.13, which is 14% above median its 10-year median of 3.63 and 98.6% above the Medical Devices & Instruments industry median of 2.08. Medartis Holding AG's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medartis Holding AG (MDRSF), the current PB Ratio is 4.13 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (MDRSF) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of $115.00 is trading 23.9% below its estimated GF Value™ of $151.13.
Key valuation signals for MDRSF:
PB Ratio: 4.13 (14% above median its 10-year median of 3.63)
GF Value™: $151.13 vs. price of $115.00 (23.9% below fair value)
Industry Position: 98.6% above the Medical Devices & Instruments median (#565 of 787)
No single metric tells the full story. See the MDRSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
82GF Score
Get the complete analysis for MDRSF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDRSF has been successfully added to your 
